Robert B. Geller - Feb 1, 2023 Form 4 Insider Report for Aravive, Inc. (ARAV)

Role
Chief Medical Officer
Signature
/s/ Abel Svitavsky, Attorney-in-fact
Stock symbol
ARAV
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/2/2023, 03:24 PM
Previous filing
Jul 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARAV Stock Option (Right to Buy) Award $0 +400K $0.00 400K Feb 1, 2023 Common Stock 400K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over three years with 50% vesting on the one-year anniversary of the date of grant and the remaining 50% vesting on a pro rata basis on a monthly basis over a two-year period commencing on the month following the one-year anniversary of the grant date.